Henry Schein Inc
Latest Henry Schein Inc News and Updates
Align Technology Traded at Its 52-Week High in September
Align Technology was trading at its 52-week high of $398.88 on September 25. The stock reported its 52-week low of $180.31 on September 28, 2017.
Wall Street Analysts Are Still Bullish on ALGN Stock
Align Technology (ALGN) stock hasn’t received any recommendation updates since the stock was upgraded by several analysts in July.
Analyzing Perrigo’s Spin-Off of Its Rx Business
In this series, we’ll analyze major spin-offs in the healthcare sector by Perrigo (PRGO), Eli Lilly (LLY), Danaher (DHR), and Henry Schein.
Henry Schein to Merge Animal Health with Vets First Choice
On April 23, Henry Schein (HSIC) announced its plans to spin off and merge its animal health business with Vets First Choice to form a joint venture, Vets First Corp.
The Key Factors in Dentsply Sirona Sales Growth Plan
Dentsply Sirona (XRAY) has delivered lower merger synergies than the company had estimated. It also took an impairment charge during 4Q17.
Align Technology and Its SmileDirectClub Partnership
In 4Q17, Align Technology reported a sequential decline in its shipments of non-Invisalign SDC aligners to SDC.
Align Technology to Execute on Key Strategic Priorities in 2018
Align Technology (ALGN) has been growing at a fast pace while it executes its strategic priorities around the world.
Align Technology’s Invisalign: Average Selling Price and Volumes
Increases in Align Technology’s (ALGN) Invisalign volumes and ASP were the major factors driving the company’s sales growth.
Align Technology: Analyst Ratings and Recommendations
Of the 12 investment research firms following ALGN stock, ten of them have given the stock “buy” or “strong buy” recommendations.
Align Technology’s Customer Acquisition Strategy Driving Market Growth
In 3Q17, Align Technology trained nearly 1,000 doctors in China.
Intuitive Surgical’s Recent Stock Split: The Market Reaction
On October 6, 2017, Intuitive Surgical will start trading on a split-adjusted basis. It has scheduled a stock split for its shares in a ratio of 3:1.
Henry Schein Acquired RxWorks and Greggs Increased Sales
Henry Schein reported 3Q15 net sales of $2,685.8 million, a rise of 2.4% compared to the net sales of $2,623.7 million in fiscal 3Q14.
How Does Patterson Companies Compare to Its Peers?
The respective PE ratios of Patterson Companies and peers Henry Schein, DENTSPLY International, and VCA are 23.6x, 27.1x, 31.5x, and 25.9x as of November 24.